Susquehanna International Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-535,907
| Closed | -$188K | – | 10657 |
|
|
2016
Q3 | $188K | Sell |
535,907
-270,449
| -34% | -$94.9K | ﹤0.01% | 7627 |
|
|
2016
Q2 | $376K | Buy |
806,356
+133,103
| +20% | +$62.1K | ﹤0.01% | 6602 |
|
|
2016
Q1 | $916K | Buy |
673,253
+164,806
| +32% | +$224K | ﹤0.01% | 5271 |
|
|
2015
Q4 | $747K | Sell |
508,447
-255,906
| -33% | -$376K | ﹤0.01% | 6011 |
|
|
2015
Q3 | $1.21M | Sell |
764,353
-231,444
| -23% | -$366K | ﹤0.01% | 5294 |
|
|
2015
Q2 | $1.69M | Buy |
995,797
+175,212
| +21% | +$298K | ﹤0.01% | 5073 |
|
|
2015
Q1 | $1.14M | Sell |
820,585
-79,020
| -9% | -$110K | ﹤0.01% | 5482 |
|
|
2014
Q4 | $1.36M | Buy |
899,605
+193,544
| +27% | +$292K | ﹤0.01% | 5250 |
|
|
2014
Q3 | $1.45M | Buy |
706,061
+125,455
| +22% | +$258K | ﹤0.01% | 5196 |
|
|
2014
Q2 | $1.78M | Buy |
580,606
+501,575
| +635% | +$1.53M | ﹤0.01% | 4888 |
|
|
2014
Q1 | $197K | Sell |
79,031
-70,413
| -47% | -$176K | ﹤0.01% | 8253 |
|
|
2013
Q4 | $741K | Sell |
149,444
-59,275
| -28% | -$294K | ﹤0.01% | 6035 |
|
|
2013
Q3 | $474K | Buy |
+208,719
| New | +$474K | ﹤0.01% | 6512 |
|
Susquehanna International Group's RXII Position: Q4 2016 in Review
Susquehanna International Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 535,907 shares — an estimated $188K sold.
Susquehanna International Group first reported a position in RXII in Q3 2013 and held it in 13 quarters. The position peaked at $1.78M in Q2 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Susquehanna International Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Susquehanna International Group sold 535,907 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $188K.
- Susquehanna International Group first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 13 quarters.
- Susquehanna International Group's GALENA BIOPHARMA INC COM position peaked at $1.78M in Q2 2014.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.